JCTC vs YMAT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JCTC exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company trades at a deep discount to book value (P/B 0.36), this appears to be a value trap given the negative profit margins (-18.23%) and declining revenue growth (-6.60%). The combination of a 0/100 technical trend and consistent insider selling suggests a lack of confidence from both the market and company leadership. Operational decay is evident in the negative ROE and ROA, making the low valuation a reflection of risk rather than opportunity.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating significant financial deterioration. While the stock appears undervalued relative to its Graham Number ($0.86) and Intrinsic Value ($0.28), these metrics are likely value traps given the catastrophic -93.7% one-year price decline and a -98.9% crash in Q/Q earnings. Despite strong YoY revenue growth, the collapse in profitability and a 0/100 technical trend suggest a company in distress.
Compare Another Pair
Related Comparisons
JCTC vs YMAT: Head-to-Head Comparison
This page compares Jewett-Cameron Trading Company Ltd. (JCTC) and J-Star Holding Co., Ltd. (YMAT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.